Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 14, 2000
Issued Date -
N/A
app pub date -
Dec 14, 1998
filing date -
Mar 9, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides an anti-idiotypic antibody having specific reactivity with an idiotope common to more than one type of anti-HIV-1 antibody, and having no specific reactivity with non-HIV-1 antibodies. The present invention provides methods of diagnosis, monitoring and treatment of HIV-related diseases through the use of this antibody or related compounds.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully